Medical approaches and future options in chronic active ulcerative colitis

By Siveke J.   Folwaczny C.  

International Journal of Colorectal Disease, Vol. 19, Iss. 4, 2004-07 ,pp. : 297-307

Springer Publishing Company

Access to resources Recommend Favorite

Prolonged Medical Therapy Increases the Risk of Surgical Complications in Patients with Severe Ulcerative Colitis

By  

Digestive Surgery, Vol. 33, Iss. 3, 2016-02 ,pp. : 182-189

Karger

Access to resources Recommend Favorite

Combination therapy using fexofenadine, disodium cromoglycate, and a hypoallergenic amino acid-based formula induced remission in a patient with steroid-dependent, chronically active ulcerative colitis

By Raithel M.   Winterkamp S.   Weidenhiller M.   Müller S.   Hahn E.  

International Journal of Colorectal Disease, Vol. 22, Iss. 7, 2007-07 ,pp. : 833-839

Springer Publishing Company

Access to resources Recommend Favorite

Fecal calprotectin and lactoferrin as predictors of relapse in patients with quiescent ulcerative colitis during maintenance therapy

By Yamamoto Takayuki   Shiraki Manabu   Bamba Takuya   Umegae Satoru   Matsumoto Koichi  

International Journal of Colorectal Disease, Vol. 29, Iss. 4, 2014-04 ,pp. : 485-491

Springer Publishing Company

Access to resources Recommend Favorite

Infliximab as a Rescue Therapy for Hospitalized Patients with Severe Ulcerative Colitis Refractory to Systemic Corticosteroids

By  

Digestive Surgery, Vol. 25, Iss. 5, 2008-11 ,pp. : 383-386

Karger

Access to resources Recommend Favorite